Meanwhile, ART improved HFD-induced hepatic steatosis and lipid metabolism-related gene expressions in Ash-NC-injected mice; however, Ash-Prkcd injection reversed ART-dependent therapeutic effects (Figure 6M-6O and S10N-S10O). The gene discussed is PRKCD; the disease is Hepatic steatosis.